125 related articles for article (PubMed ID: 2526666)
1. Histologic typing of non-Hodgkin's lymphomas by in situ hybridization with DNA probes of oncogenes.
Hamatani K; Yoshida K; Kondo H; Toki H; Okabe K; Motoi M; Ikeda S; Mori S; Shimaoka K; Akiyama M
Blood; 1989 Jul; 74(1):423-9. PubMed ID: 2526666
[TBL] [Abstract][Full Text] [Related]
2. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
Lee JT; Innes DJ; Williams ME
J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518
[TBL] [Abstract][Full Text] [Related]
3. Expression of cellular oncogenes in primary cells from human acute leukemias.
Mavilio F; Sposi NM; Petrini M; Bottero L; Marinucci M; De Rossi G; Amadori S; Mandelli F; Peschle C
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4394-8. PubMed ID: 3520570
[TBL] [Abstract][Full Text] [Related]
4. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade.
Harvey WH; Harb OS; Kosak ST; Sheaffer JC; Lowe LR; Heerema NA
Leuk Res; 1994 Aug; 18(8):577-85. PubMed ID: 7520517
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of ras genes in non-Hodgkin's lymphomas is not associated with oncogenic activation of those genes by point mutation.
Hamatani K; Nagata Y; Abe M; Abe K; Toki H; Ikeda S; Nakayama E; Shiku H
Jpn J Cancer Res; 1989 Aug; 80(8):706-10. PubMed ID: 2511175
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques.
Mitani S; Sugawara I; Shiku H; Mori S
Cancer; 1988 Nov; 62(10):2085-93. PubMed ID: 3052780
[TBL] [Abstract][Full Text] [Related]
7. Detection of canine homologs of human MYC, BCL2, IGH, and TCRB genes by Southern blot analysis.
Chaganti SR; Mitra J; LoBue J
Cancer Genet Cytogenet; 1992 Aug; 62(1):9-14. PubMed ID: 1387833
[TBL] [Abstract][Full Text] [Related]
8. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
[TBL] [Abstract][Full Text] [Related]
9. Analysis of BCL2 and MYC expression in non-Hodgkin's lymphomas by in situ hybridization: correlation with chromosome translocations.
Murty VV; Ladanyi M; Houldsworth J; Mikraki V; Chaganti RS
Diagn Mol Pathol; 1992 Dec; 1(4):221-8. PubMed ID: 1342969
[TBL] [Abstract][Full Text] [Related]
10. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
11. The transgenic window on lymphoid malignancy.
Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
[TBL] [Abstract][Full Text] [Related]
12. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
[TBL] [Abstract][Full Text] [Related]
13. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
14. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
[TBL] [Abstract][Full Text] [Related]
15. Expression of oncogenes in human hepatoma cell lines.
Ting LP; Jeng KS; Chou CK; Su TS; Hu CP; Wong FH; Chang HK; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Aug; 21(3):141-50. PubMed ID: 2854043
[TBL] [Abstract][Full Text] [Related]
16. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.
Dyer MJ; Lillington DM; Bastard C; Tilly H; Lens D; Heward JM; Stranks G; Morilla R; Monrad S; Guglielmi P; Kluin-Nelemans JC; Hagemeijer A; Young BD; Catovsky D
Leukemia; 1996 Jul; 10(7):1198-208. PubMed ID: 8684002
[TBL] [Abstract][Full Text] [Related]
17. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
Dolcetti R; Pelucchi S; Maestro R; Rizzo S; Pastore A; Boiocchi M
Eur Arch Otorhinolaryngol; 1991; 248(5):279-85. PubMed ID: 1679639
[TBL] [Abstract][Full Text] [Related]
18. Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
Nakamine H; Masih AS; Chan WC; Sanger WG; Armitage JO; Weisenburger DD
Leuk Lymphoma; 1993 May; 10(1-2):79-88. PubMed ID: 8374527
[TBL] [Abstract][Full Text] [Related]
19. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
20. Detection of oncogene rearrangements in human non-Hodgkin's lymphomas.
Kondo E; Yoshino T; Akagi T; Hayashi K; Takahashi K
Acta Med Okayama; 1992 Dec; 46(6):407-15. PubMed ID: 1485535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]